학술논문

Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients
Document Type
Article
Source
In: Immuno. (Immuno, September 2021, 1(3):253-263)
Subject
Language
English
ISSN
26735601